Portfolio company
3X Genetics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops long-read genetic testing technology and diagnostics for biopharma companies to identify patients with rare repeat expansion disorders.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Genetic Sequencing
This company develops nanopore-based technology for DNA sequencing to support researchers and clinicians in medical diagnostics and genomic analysis.
Nostos Genomics
The company develops an automated software platform for variant interpretation that helps genetic testing laboratories diagnose patients with rare diseases.
Iris Medicine
This life sciences company develops allele-selective ribonucleic acid therapies to treat genetic diseases in patients with repeat expansion disorders.
Spot Biosystems
This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.
VUS Genetics
This company develops high-throughput functional assays for drug developers to classify gene variants and improve patient stratification in oncology and rare disease clinical trials.
Codebreaker
This company develops a synthetic biology platform generating causal genomics data to help clinicians and researchers interpret genetic variants for disease diagnosis.
Single molecule diagnostics
This company develops prenatal screening and oncology liquid biopsy tests for clinicians to identify genetic risks and monitor cancer treatments in patients.
Cytox
This company develops non-invasive genetic tests for Alzheimer's disease risk assessment and patient stratification for clinicians and pharmaceutical researchers.
